Chan OS - Search Results

1

Staging of nasopharyngeal carcinoma--the past, the present and the future.

Ng WT, Yuen KT, Au KH, Chan OS, Lee AW. Ng WT, et al. Among authors: chan os. Oral Oncol. 2014 Jun;50(6):549-54. doi: 10.1016/j.oraloncology.2013.06.003. Epub 2013 Jul 6. Oral Oncol. 2014. PMID: 23838426 Review.

2

Clinical outcomes and patterns of failure after intensity-modulated radiotherapy for nasopharyngeal carcinoma.

Ng WT, Lee MC, Hung WM, Choi CW, Lee KC, Chan OS, Lee AW. Ng WT, et al. Among authors: chan os. Int J Radiat Oncol Biol Phys. 2011 Feb 1;79(2):420-8. doi: 10.1016/j.ijrobp.2009.11.024. Epub 2010 May 6. Int J Radiat Oncol Biol Phys. 2011. PMID: 20452132

3

The superiority of hybrid-volumetric arc therapy (VMAT) technique over double arcs VMAT and 3D-conformal technique in the treatment of locally advanced non-small cell lung cancer--a planning study.

Chan OS, Lee MC, Hung AW, Chang AT, Yeung RM, Lee AW. Chan OS, et al. Radiother Oncol. 2011 Nov;101(2):298-302. doi: 10.1016/j.radonc.2011.08.015. Epub 2011 Sep 8. Radiother Oncol. 2011. PMID: 21907438

4

Radical radiotherapy for nasopharyngeal carcinoma in elderly patients: the importance of co-morbidity assessment.

Sze HC, Ng WT, Chan OS, Shum TC, Chan LL, Lee AW. Sze HC, et al. Among authors: chan ll, chan os. Oral Oncol. 2012 Feb;48(2):162-7. doi: 10.1016/j.oraloncology.2011.08.019. Epub 2011 Sep 16. Oral Oncol. 2012. PMID: 21925925

5

The strength/weakness of the AJCC/UICC staging system (7th edition) for nasopharyngeal cancer and suggestions for future improvement.

Lee AWM, Ng WT, Chan LK, Chan OSH, Hung WM, Chan CC, Cheng PTC, Sze H, Lam TS, Yau TK. Lee AWM, et al. Oral Oncol. 2012 Oct;48(10):1007-1013. doi: 10.1016/j.oraloncology.2012.03.022. Epub 2012 Apr 22. Oral Oncol. 2012. PMID: 22525607

6

Stereotactic ablative radiotherapy for medically inoperable early stage lung cancer: early outcomes.

Chan OS, Yeung RM, Hung AW, Lee MC, Chang AT, Chan CC, Lee AW. Chan OS, et al. Among authors: chan cc. Hong Kong Med J. 2012 Oct;18(5):412-8. Hong Kong Med J. 2012. PMID: 23018069 Free article.

7

Individualized treatment in stage IVC nasopharyngeal carcinoma.

Chan OS, Ngan RK. Chan OS, et al. Oral Oncol. 2014 Sep;50(9):791-7. doi: 10.1016/j.oraloncology.2014.01.004. Epub 2014 Feb 8. Oral Oncol. 2014. PMID: 24518920 Review.

8

The impact of dosimetric inadequacy on treatment outcome of nasopharyngeal carcinoma with IMRT.

Ng WT, Lee MC, Chang AT, Chan OS, Chan LL, Cheung FY, Hung WM, Chan CC, Lee AW. Ng WT, et al. Among authors: chan ll, chan cc, chan os. Oral Oncol. 2014 May;50(5):506-12. doi: 10.1016/j.oraloncology.2014.01.017. Epub 2014 Feb 13. Oral Oncol. 2014. PMID: 24529762

9

Evolution of treatment for nasopharyngeal cancer--success and setback in the intensity-modulated radiotherapy era.

Lee AW, Ng WT, Chan LL, Hung WM, Chan CC, Sze HC, Chan OS, Chang AT, Yeung RM. Lee AW, et al. Among authors: chan ll, chan cc, chan os. Radiother Oncol. 2014 Mar;110(3):377-84. doi: 10.1016/j.radonc.2014.02.003. Epub 2014 Mar 11. Radiother Oncol. 2014. PMID: 24630534 Review.

10

Should all nasopharyngeal carcinoma with masticator space involvement be staged as T4?

Sze H, Chan LL, Ng WT, Hung AW, Lee MC, Chang AT, Chan OS, Cheung FY, Yeung RM, Lee AW. Sze H, et al. Among authors: chan ll, chan os. Oral Oncol. 2014 Dec;50(12):1188-95. doi: 10.1016/j.oraloncology.2014.09.001. Epub 2014 Sep 30. Oral Oncol. 2014. PMID: 25261296

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

41 results

Search Page

Filters